Consumer Retailing Healthcare Sector

KALA BIO

Market Cap: US$26.4m

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare and severe eye diseases.

Harvard Apparatus Regenerative Technology

Market Cap: US$26.3m

A clinical-stage biotechnology company, focuses on developing regenerative-medicine treatments for disorders of the gastro-intestinal system and other organs resulting from cancer, trauma, or birth defects.

Innovative MedTech

Market Cap: US$26.1m

Through its subsidiaries, engages in the provision of health and wellness services in the United States.

Kun Peng International

Market Cap: US$26.0m

Engages in the distribution of health care and health-related household products through its online platforms in the People’s Republic of China.

CytoMed Therapeutics

Market Cap: US$26.0m

A pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers and degenerative diseases in Malaysia and Singapore.

Advanced Biomed

Market Cap: US$25.8m

An investment holding company, engages in the research and development of microfluidic biochip technologies and provides them for precision oncology detection, diagnosis, and treatment in Taiwan.

Scilex Holding

Market Cap: US$25.7m

Focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain.

Daré Bioscience

Market Cap: US$25.7m

A biopharmaceutical company, develops therapies in the areas of contraception, reproductive health, menopause, fertility, and sexual and vaginal health in the United States.

Chemomab Therapeutics

Market Cap: US$25.6m

A clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases in the United States.

ALX Oncology Holdings

Market Cap: US$25.6m

A clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States.

Generation Bio

Market Cap: US$25.5m

A biotechnology company, discovers, develops, and commercializes redosable therapeutics that reprogram T cells in vivo to reduce or eliminate the production and persistence of autoreactive T cells.

Oncotelic Therapeutics

Market Cap: US$25.2m

A clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment of orphan oncology indications.

Prescient Therapeutics

Market Cap: AU$38.3m

A clinical stage oncology company, develops drugs for the treatment of various cancers in Australia.

China SXT Pharmaceuticals

Market Cap: US$24.8m

A pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China.

iAnthus Capital Holdings

Market Cap: CA$33.7m

Owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States.

Micro-X

Market Cap: AU$37.4m

Designs, develops, manufactures, and commercializes healthcare and security markets products using micro-X proprietary cold cathode X-ray technology in Australia, the United States, Asia-Pacific, Europe, the Middle East, and Africa.

Thiogenesis Therapeutics

Market Cap: CA$33.2m

A biopharmaceutical company, develops thiol-based therapeutic compounds to treat unmet pediatric medical needs.

MediPharm Labs

Market Cap: CA$33.2m

Operates as a pharmaceutical company that produces and sells purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally.

Starpharma Holdings

Market Cap: AU$37.2m

A biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications worldwide.

CalciMedica

Market Cap: US$23.9m

A clinical-stage biopharmaceutical company, focuses on developing therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage.

Doctor Care Anywhere Group

Market Cap: AU$36.7m

Provides digital healthcare and development services in the United Kingdom and the Republic of Ireland.

BioAtla

Market Cap: US$23.8m

A clinical-stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer.

Vaso

Market Cap: US$23.7m

Operates in the healthcare equipment and information technology industries in the United States and internationally.

Grey Wolf Animal Health

Market Cap: CA$32.5m

Operates as an animal health and wellness company in Canada.

Inspiration Healthcare Group

Market Cap: UK£17.5m

Designs, manufactures, and sells medical technology products worldwide.

FLUENT

Market Cap: US$23.6m

Through its subsidiaries, cultivates, manufactures processes, distributes, and sells medical cannabis products for medical and adult-use markets in Florida, New York, Pennsylvania, and Texas.

Pulmatrix

Market Cap: US$23.5m

A clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States.

QT Imaging Holdings

Market Cap: US$23.5m

Engages in the research, development, and commercialization of body imaging systems with low frequency sound waves for detection, diagnosis, monitoring, and treatment of diseases in the United States and Internationally.

Eagle Pharmaceuticals

Market Cap: US$23.4m

A pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States.

CleanSpace Holdings

Market Cap: AU$35.9m

Engages in the design, manufacture, and sale of respiratory protection products and services for healthcare and industrial markets worldwide.

OSR Holdings

Market Cap: US$23.3m

A healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Switzerland, and South Korea.

Vor Biopharma

Market Cap: US$23.3m

Operates as a clinical-stage cell and genome engineering company.

Cryosite

Market Cap: AU$35.9m

Provides outsourced clinical trials logistic services in Australia.

NanoViricides

Market Cap: US$23.1m

A clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections.

Propanc Biopharma

Market Cap: US$23.1m

A biopharmaceutical company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia.

Nanalysis Scientific

Market Cap: CA$31.7m

Develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Europe, Asia, and internationally.